1974Journal of NeurochemistryRequires access

PROTEIN SYNTHESIS BY CEREBRAL POLYSOMES PRETREATED WITH PUROMYCIN

M.R.V. Murthy, H Roux

Open publisher page 4 citations

Abstract

Abstract— Polysomes prepared from rat cerebral microsomes, following preincubation with a high concentration of puromycin (2.5 mM) in the presence of rat liver soluble enzymes, were very similar to normal polysomes in yield, A 260nm:A 280nm ratio and in absorbance profile on sucrose density gradients. However, the capacity for amino acid incorporation was inhibited by more than 50 per cent by puromycin treatment. The extent of inhibition far exceeded what could be expected from the amount of residual puromycin bound to polysomes, suggesting that some essential step in polypeptide synthesis was damaged. An examination of the labelled polypeptides, using sucrose density gradient centrifugation, showed that most of the new chains synthesized by puromycin‐polysomes were released into solution. However, small amounts of polypeptides of high specific radioactivity were distributed among the polysomal aggregates. In contrast to normal polysomes, the specific radioactivity of puromycin polysomes was the highest in aggregates of six or more ribosomes and declined sharply at the levels of trimers and dimers. It is suggested that cerebral polysomes pretreated with puromycin become defective in the termination mechanism with the consequence that even though they are capable of moving at least short distances on the messenger RNA and of releasing the polypeptide chains formed, a concomittant release of monomeric ribosomes is obstructed. This may result in the‘clogging’of the terminus of the mRNA, thus blocking further polypeptide synthesis.

About this research paper

What this paper is about

Abstract— Polysomes prepared from rat cerebral microsomes, following preincubation with a high concentration of puromycin (2.5 mM) in the presence of rat liver soluble enzymes, were very similar to normal polysomes in yield, A 260nm:A 280nm ratio and in absorbance profile on sucrose density gradients. However, the capacity for amino acid incorporation was inhibited by more than 50 per cent by puromycin treatment. The extent of inhibition far exceeded what could be expected from the amount of residual puromycin bound to polysomes, suggesting that some essential step in polypeptide synthesis was damaged. An examination of the labelled polypeptides, using sucrose density gradient centrifugation, showed that most of the new chains synthesized by puromycin‐polysomes were released into solution. However, small amounts of polypeptides of high specific radioactivity were distributed among the polysomal aggregates. In contrast to normal polysomes, the specific radioactivity of puromycin polysomes was the highest in aggregates of six or more ribosomes and declined sharply at the levels of trimers and dimers. It is suggested that cerebral polysomes pretreated with puromycin become defective in the termination mechanism with the consequence that even though they are capable of moving at least short distances on the messenger RNA and of releasing the polypeptide chains formed, a concomittant release of monomeric ribosomes is obstructed. This may result in the‘clogging’of the terminus of the mRNA, thus blocking further polypeptide synthesis.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract— Polysomes prepared from rat cerebral microsomes, following preincubation with a high concentration of puromycin (2.5 mM) in the presence of rat liver soluble enzymes, were very similar to normal polysomes in yield, A 260nm:A 280nm ratio and in absorbance profile on sucrose density gradients. However, the capacity for amino acid incorporation was inhibited by more than 50 per cent by puromycin treatment. The extent of inhibition far exceeded what could be expected from the amount of residual puromycin bound to polysomes, suggesting that some essential step in polypeptide synthesis was damaged. An examination of the labelled polypeptides, using sucrose density gradient centrifugation, showed that most of the new chains synthesized by puromycin‐polysomes were released into solution. However, small amounts of polypeptides of high specific radioactivity were distributed among the polysomal aggregates. In contrast to normal polysomes, the specific radioactivity of puromycin polysomes was the highest in aggregates of six or more ribosomes and declined sharply at the levels of trimers and dimers. It is suggested that cerebral polysomes pretreated with puromycin become defective in the termination mechanism with the consequence that even though they are capable of moving at least short distances on the messenger RNA and of releasing the polypeptide chains formed, a concomittant release of monomeric ribosomes is obstructed. This may result in the‘clogging’of the terminus of the mRNA, thus blocking further polypeptide synthesis.

Key concepts: Puromycin, Polysome, Ribosome, Protein biosynthesis, Biochemistry, Messenger RNA, Sucrose, Microsome

Related papers

Back to paper searchBrowse research topicsOriginal source
PROTEIN SYNTHESIS BY CEREBRAL POLYSOMES PRETREATED WITH PUROMYCIN — Research Paper | ScholarLens